In conclusion, the safety profile of semaglutide in obesity treatment is generally favorable, but post marketing surveillance will give physicians and patients a greater clarity
Paracetamol (5001000 mg every 46 hours, maximum 4 g daily) represents a safe first-line option for most patients
For example, some people may experience mild nausea, while others may have frequent diarrhea
Recent studies have indicated that GLP-1RAs may possess neuroprotective properties (12) and directly reduce ICP
The medication is given once weekly on the same day, but you can change the day of the week if needed (by adjusting the interval between doses)
There is no established direct mechanism by which semaglutide causes erectile dysfunction, and ED is not listed as a recognized adverse effect in FDA prescribing information